• Shanghai Industrial Investment’s unit Shanghai Pharma Chairman Yang Qiuhua joined a group visit to herbal-medicine arm Shangyao Medicinal Materials on July 15, 2026.
• The group signaled a push to scale the traditional Chinese medicine supply chain, emphasizing traceability, smart-manufacturing upgrades, brand refresh, compliance controls.
• Shangyao Medicinal Materials was positioned as the group’s only full-industry-chain Chinese medicinal materials platform, with a strategic focus on governance streamlining, digitalization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Industrial Investment Holdings Co Ltd published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.